Results 41 to 50 of about 197,573 (365)

Fixed drug eruption associated with fixed combination of fluoroquinolone-nitroimidazole [PDF]

open access: yes, 2021
Fixed drug eruptions (FDE) are cutaneous adverse drug reaction characterized by well demarcated erythematous plaques which on removal of the offending agent resolves with residual hyperpigmentation patches at the site.
Kiruthika, S.   +3 more
core   +2 more sources

Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine

open access: yesBMJ Case Reports, 2021
A 51-year-old woman with Crohn’s disease presented with a bullous rash on her left arm and axilla 2 days after receiving her second dose of the recombinant adjuvant Shingrix vaccine.
Hallie Thompson   +2 more
semanticscholar   +1 more source

Dental management before radiotherapy of the head and neck region: 4‐year single‐center experience

open access: yesClinical and Experimental Dental Research, Volume 8, Issue 6, Page 1478-1486, December 2022., 2022
Abstract Objective To review our experience with a standardized dental management approach in patients with planned radiotherapy of the head and neck region based on preradiation and follow‐up data. Material and Methods Records of patients who underwent radiotherapy between June 2016 and November 2020 were reviewed.
Lea Hoffmann   +5 more
wiley   +1 more source

Generalized Bullous Fixed Drug Eruption to Fluconazole with Positive Patch Testing and Confirmed Tolerance to Itraconazole.

open access: yesIranian Journal of Allergy, Asthma and Immunology, 2021
Generalized bullous fixed drug eruption (GBFDE) is a specific variant of fixed drug eruption that belongs to severe cutaneous adverse reactions (SCARs) and its diagnosis is based mainly on clinical course and especially on the reoccurrence of typical ...
M. Makris   +5 more
semanticscholar   +1 more source

Suspected Ticagrelor-Induced Bullous Fixed Drug Eruption

open access: yesCureus, 2021
We describe a case of a suspected cutaneous hypersensitivity reaction to ticagrelor. The patient displayed a localized bullous fixed drug eruption after being loaded with ticagrelor, which resolved with oral antihistamines and topical steroids after one ...
Tiffany Kawall   +4 more
semanticscholar   +1 more source

Fixed Drug Eruption to Trimethoprim-Sulfamethoxazole and Doxycycline

open access: yesCureus, 2021
Fixed drug eruption (FDE) is a common cutaneous drug eruption. We are the first to report a case of polysensitive FDE to both trimethoprim-sulfamethoxazole (TMP-SMX) and doxycycline.
C. Long, Noelle Wong, Ariel M. Burns
semanticscholar   +1 more source

Charting the landscape of the environmental exposome

open access: yesiMeta, Volume 1, Issue 4, December 2022., 2022
We describe the biological and chemical components of the environmental exposomes in three major environmental matrices that are highly relevant to human and social‐economical health—air, soil, and water. We discuss how different exposome components can interact with each other. Finally, we propose a list of outstanding challenges to be tackled to push
Xin Wei   +6 more
wiley   +1 more source

Gene Therapy Using Recombinant AAV Type 8 Vector Encoding TNAP‐D10 Improves the Skeletal Phenotypes in Murine Models of Osteomalacia

open access: yesJBMR Plus, Volume 7, Issue 1, January 2023., 2023
ABSTRACT Hypophosphatasia (HPP), caused by loss‐of‐function mutations in the ALPL gene encoding tissue‐nonspecific alkaline phosphatase (TNAP), is characterized by skeletal and dental hypomineralization that can vary in severity from life‐threatening to milder manifestations only in adulthood.
Flavia Amadeu de Oliveira   +7 more
wiley   +1 more source

Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination

open access: yesClincal and Experimental Dermatology, 2021
A 74-year-old Thai male presented with a rash appearing 25 hours after receiving the first dose of the adenoviral-vectored COVID-19 vaccine, ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca).
K. Wantavornprasert   +3 more
semanticscholar   +1 more source

Ofloxacin/ tinidazole induced fixed drug eruption- a case report

open access: yesJournal of Pharmacovigilance and Drug Research, 2021
Introduction: An immunological cutaneous adverse drug reaction is distinguished as sharply defined lesions with red rashes and sharp borders, erythematous lesions with or without blisters developing within an hour or in a few cases within a week after ...
Monika Kapoor
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy